Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
oxycodone	O
/	O
hydrocodone	O
/	O
Penicillins	O
Attending:	O
___	O
Chief	O
Complaint:	O
absent	O
pulses	O
in	O
lower	O
extremities	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
Panniculectomy	O
___	O
History	O
of	O
Present	O
Illness:	O
Ms.	O
___	O
is	O
a	O
___	O
woman	O
with	O
a	O
history	O
of	O
severe	O
peripheral	O
vascular	O
disease,	O
obesity,	O
CAD	O
s/p	O
MI	O
w/	O
PCI	O
c/b	O
left	O
circumflex	O
perforation,	O
DMII,	O
hypertension,	O
chronic	O
myeloid	O
leukemia	O
s/p	O
SCT	O
c/b	O
GVHD,	O
and	O
chronic	O
ulcerations	O
on	O
her	O
pannus	O
who	O
presents	O
with	O
concern	O
for	O
loss	O
of	O
pulses	O
in	O
her	O
lower	O
extremities.	O
In	O
terms	O
of	O
her	O
PVD,	O
she	O
is	O
s/p	O
bilateral	O
iliac	O
stenting	O
(___)	O
with	O
subsequent	O
occlusion	O
and	O
recent	O
ABI	O
of	O
0.2	O
bilaterally.	O
Per	O
vascular	O
surgery,	O
the	O
plan	O
has	O
been	O
consideration	O
of	O
bilateral	O
amputations	O
vs.	O
bypass	O
surgery,	O
but	O
this	O
has	O
been	O
difficult	O
in	O
light	O
of	O
chronic	O
MRSA-infected	O
ulcerations	O
in	O
her	O
pannus	O
requiring	O
multiple	O
hospitalizations	O
at	O
___.	O
She	O
was	O
referred	O
to	O
plastic	O
surgery	O
for	O
management	O
of	O
these	O
ulcerations.	O
Plastics	O
has	O
recommended	O
weekly	O
debridements	O
with	O
ultimate	O
panniculectomy.	O
On	O
___,	O
she	O
presented	O
for	O
routine	O
follow-up	O
at	O
___	O
where	O
she	O
was	O
noted	O
to	O
appear	O
"anemic	O
and	O
undernourished"	O
by	O
nursing	O
staff.	O
She	O
was	O
sent	O
to	O
___	O
where	O
she	O
was	O
found	O
to	O
have	O
no	O
distal	O
___	O
pulses	O
and	O
was	O
sent	O
to	O
___	O
for	O
evaluation	O
by	O
plastics	O
and	O
vascular	O
surgery.	O
In	O
the	O
ED,	O
vascular	O
surgery	O
was	O
consulted.	O
They	O
noted	O
discoloration	O
of	O
her	O
right	O
first	O
toe	O
and	O
concern	O
for	O
gangrene	O
in	O
the	O
tips	O
of	O
her	O
left	O
___	O
and	O
___	O
toes.	O
There	O
were	O
no	O
palpable	O
pulses	O
in	O
the	O
lower	O
extremities,	O
which	O
apparently	O
is	O
her	O
baseline.	O
She	O
was	O
noted	O
to	O
have	O
had	O
a	O
CTA	O
at	O
OSH	O
with	O
three-vessel	O
runoff.	O
They	O
determined	O
that	O
there	O
were	O
no	O
acute	O
vascular	O
surgery	O
needs.	O
She	O
later	O
became	O
agitated	B-Dementia
and	O
was	O
noted	O
to	O
be	O
yelling,	O
cursing,	O
and	O
kicking	O
and	O
swatting	O
staff.	O
She	O
was	O
given	O
IM	O
olanzapine	O
and	O
Haldol.	O
She	O
stated	O
that	O
she	O
was	O
in	O
a	O
house	O
and	O
that	O
she	O
was	O
going	O
to	O
call	O
the	O
police.	O
She	O
removed	O
her	O
PIV	O
and	O
refused	O
vitals	O
checks	O
and	O
medications.	O
She	O
later	O
became	O
more	O
calm,	O
but	O
continued	O
to	O
be	O
disoriented	B-Unspecified_cognitive_impairment
and	O
called	O
the	O
police.	O
In	O
the	O
ED,	O
initial	O
vital	O
signs	O
were	O
notable	O
for:	O
T	O
98.3F	O
HR	O
70	O
BP	O
128/43	O
RR	O
16	O
O2	O
99%	O
RA	O
Exam	O
notable	O
for:	O
-	O
Pannus	O
with	O
multiple	O
ulcerations	O
with	O
surrounding	O
erythema	O
and	O
fibrinous	O
exudate	O
covered	O
by	O
gauze.	O
3	O
large	O
ulcerations	O
measuring	O
4-8cm	O
lengthwise	O
and	O
multiple	O
1-3cm	O
punctate	O
ulcerations.	O
-	O
8x3cm	O
ulcer	B-Pressure_injury
over	B-Pressure_injury
sacrum.	B-Pressure_injury
-	O
No	O
DP	O
or	O
posterior	O
tibial	O
pulses	O
bilaterally,	O
dorsum	O
of	O
feet	O
are	O
warm.	O
___	O
digit	O
of	O
both	O
feet	O
dusky	O
with	O
dry	O
blackened	O
scabs,	O
duskiness	O
over	O
___	O
digits,	O
no	O
exudate.	O
Labs	O
were	O
notable	O
for:	O
WBC	O
18.5	O
Hgb	O
7.8	O
Plt	O
439	O
Lactate	O
2.4	O
UA	O
with	O
leukocytes	O
Studies	O
performed	O
include:	O
CTA	O
Aorta	O
Bifem	O
Iliac	O
___:	O
1.	O
Redemonstration	O
of	O
occlusion	O
of	O
the	O
distal	O
infrarenal	O
abdominal	O
aorta	O
at	O
the	O
site	O
of	O
the	O
bilateral	O
common	O
iliac	O
stents	O
with	O
reconstitution	O
of	O
flow	O
in	O
the	O
bilateral	O
common	O
iliac	O
arteries	O
from	O
multiple	O
collaterals.	O
2.	O
Three-vessel	O
runoff	O
is	O
identified	O
bilaterally	O
to	O
the	O
level	O
of	O
the	O
ankle,	O
with	O
slower	O
flow	O
noted	O
in	O
the	O
bilateral	O
anterior	O
tibial	O
and	O
peroneal	O
arteries.	O
The	O
dorsalis	O
pedis	O
arteries	O
are	O
not	O
well	O
visualized	O
on	O
either	O
side,	O
and	O
there	O
is	O
likely	O
retrograde	O
filling	O
of	O
the	O
right	O
dorsalis	O
pedis	O
from	O
multiple	O
plantar	O
arteries.	O
3.	O
Mild	O
to	O
moderate	O
stenosis	O
identified	O
in	O
the	O
abdominal	O
major	O
branches,	O
iliac	O
and	O
femoral	O
arteries,	O
due	O
to	O
atherosclerotic	O
calcified	O
and	O
noncalcified	O
plaque,	O
detailed	O
above.	O
4.	O
Possible	O
nonobstructing	O
2-3	O
mm	O
left	O
upper	O
renal	O
pole	O
stone	O
versus	O
vascular	O
calcification.	O
Patient	O
was	O
given:	O
IV	O
CefTRIAXone	O
1	O
g	O
IV	O
Vancomycin	O
1000	O
mg	O
IM	O
Haloperidol	O
2.5	O
mg	O
x2	O
IM	O
OLANZapine	O
5	O
mg	O
x2	O
PO/NG	O
HYDROmorphone	O
(Dilaudid)	O
2	O
mg	O
PO/NG	O
Citalopram	O
10	O
mg	O
PO/NG	O
Pregabalin	O
50	O
mg	O
PO	O
Isosorbide	O
Mononitrate	O
(Extended	O
Release)	O
30	O
mg	O
PO/NG	O
Losartan	O
Potassium	O
50	O
mg	O
PO	O
MetFORMIN	O
XR	O
(Glucophage	O
XR)	O
1000	O
mg	O
PO	O
Metoprolol	O
Succinate	O
XL	O
50	O
mg	O
PO	O
Omeprazole	O
20	O
mg	O
PO/NG	O
amLODIPine	O
5	O
mg	O
PO/NG	O
rOPINIRole	O
1	O
mg	O
Upon	O
arrival	O
to	O
the	O
floor,	O
the	O
patient	O
is	O
calm.	O
She	O
reports	O
pain	O
in	O
her	O
bilateral	O
feet,	O
lower	O
back	O
at	O
the	O
site	O
of	O
her	O
wound,	O
and	O
lower	O
abdomen.	O
She	O
says	O
that	O
she	O
had	O
some	O
diarrhea	O
several	O
days	O
ago,	O
but	O
it	O
has	O
since	O
resolved.	O
She	O
denies	O
chest	O
pain,	O
abdominal	O
pain	O
(besides	O
her	O
wound	O
pain),	O
N/V.	O
Past	O
Medical	O
History:	O
CAD	O
s/p	O
MI	O
w/	O
failed	O
PCI	O
attempt,	O
c/b	O
perforation	O
of	O
left	O
Circumflex	O
HTN	O
HLD	O
Obesity	O
DMII	O
PVD	O
with	O
necrotic	O
toe	O
ulceration	O
CML	O
s/p	O
SCT	O
Anxiety	O
Depression	O
Diverticulitis	O
Psoriasis	O
Restless	O
leg	O
syndrome	O
Neuropathy	O
Chronic	O
pannus	O
ulcers	O
s/p	O
panniculectomy	O
___	O
Possible	O
dementia,	B-Dementia
planned	O
neurocognitive	O
assessment	O
Social	O
History:	O
___	O
Family	O
History:	O
The	O
patient's	O
father	O
died	O
in	O
___	O
secondary	O
to	O
a	O
propane	O
explosion.	O
The	O
patient	O
had	O
12	O
siblings	O
there	O
were	O
total	O
13,	O
one	O
was	O
stillborn.	O
Physical	O
Exam:	O
Admission	O
physical	O
exam:	O
VITALS:	O
24	O
HR	O
Data	O
(last	O
updated	O
___	O
@	O
2144)	O
Temp:	O
99.6	O
(Tm	O
99.6),	O
BP:	O
131/70,	O
HR:	O
81,	O
RR:	O
20,	O
O2	O
sat:	O
96%,	O
O2	O
delivery:	O
Ra,	O
Wt:	O
185.85	O
lb/84.3	O
kg	O
GENERAL:	O
calm	O
elderly	O
woman,	O
pleasant,	O
AxOx3.	B-Delirium
HEENT:	O
Normocephalic,	O
atraumatic.	O
Pupils	O
equal,	O
round,	O
and	O
reactive	O
bilaterally,	O
extraocular	O
muscles	O
intact.	O
Sclera	O
anicteric	O
and	O
without	O
injection.	O
Moist	O
mucous	O
membranes,	O
good	O
dentition.	O
Oropharynx	O
is	O
clear.	O
CARDIAC:	O
Regular	O
rhythm,	O
normal	O
rate.	O
Audible	O
S1	O
and	O
S2.	O
No	O
murmurs/rubs/gallops.	O
LUNGS:	O
Clear	O
to	O
auscultation	O
bilaterally	O
w/appropriate	O
breath	O
sounds	O
appreciated	O
in	O
all	O
fields.	O
No	O
wheezes,	O
rhonchi	O
or	O
rales.	O
No	O
increased	O
work	O
of	O
breathing.	O
ABDOMEN:	O
Obese.	O
Pannus	O
with	O
multiple	O
open	O
ulcers	O
with	O
fibrinous/purulent	O
base	O
and	O
surrounding	O
erythema.	O
Normal	O
bowels	O
sounds,	O
non	O
distended,	O
non-tender	O
to	O
palpation	O
BACK:	O
sacral	B-Pressure_injury
wound	B-Pressure_injury
with	O
overlying	O
eschar	O
EXTREMITIES:	O
Dusky	O
discoloration	O
of	O
the	O
right	O
first	O
toe	O
with	O
ulceration.	O
In	O
addition,	O
she	O
has	O
superficial	O
gangrene	O
in	O
the	O
tips	O
of	O
the	O
left	O
second	O
and	O
third	O
toes.	O
There	O
are	O
no	O
palpable	O
pulses	O
in	O
the	O
lower	O
extremities.	O
NEUROLOGIC:	O
CN2-12	O
intact.	O
AOx3.	B-Delirium
Discharge	O
physical	O
Exam:	O
___	O
0726	O
Temp:	O
97.9	O
PO	O
BP:	O
153/71	O
R	O
Lying	O
HR:	O
76	O
RR:	O
18	O
O2	O
sat:	O
98%	O
O2	O
delivery:	O
Ra	O
FSBG:	O
97	O
GENERAL:	O
Alert,	O
pleasant	O
elderly	O
woman,	O
lying	O
in	O
bed,	O
in	O
no	O
acute	O
distress.	O
HEENT:	O
sclera	O
anicteric	O
CARDIAC:	O
RRR,	O
nl	O
s1/s2,	O
no	O
m/g/r	O
appreciated.	O
LUNGS:	O
CTAB.	O
No	O
w/r/r	O
appreciated.	O
No	O
increased	O
WOB.	O
ABDOMEN:	O
Large	O
horizontal	O
incision	O
along	O
the	O
abdomen	O
with	O
incisional	O
vac	O
in	O
place.	O
No	O
erythema,	O
induration,	O
or	O
tenderness	O
surrounding	O
the	O
incision.	O
2	O
JP	O
drains	O
in	O
place,	O
L	O
drain	O
5	O
ml	O
serosanguinous	O
fluid,	O
R	O
drain	O
with	O
5	O
mL	O
serosanguinous	O
output.	O
BACK:	O
Sacral	B-Pressure_injury
pressure	B-Pressure_injury
ulcer	B-Pressure_injury
under	O
mepilex	O
(ulcer	O
is	O
stage	O
II).	O
No	O
erythema	O
or	O
induration	O
surrounding	O
ulcer.	O
EXTREMITIES:	O
Feet	O
with	O
gauze	O
dressings	O
around	O
toes	O
c/d/I;	O
betadine	O
visible	O
on	O
gauze	O
on	O
R	O
foot	O
NEUROLOGIC:	O
AAOx2	B-Unspecified_cognitive_impairment
(not	O
oriented	O
to	O
date),	O
occasionally	O
forgetful,	B-Unspecified_cognitive_impairment
CN2-12	O
grossly	O
intact.	O
Moving	O
___.	O
No	O
tremor	O
noted.	O
Pertinent	O
Results:	O
Admission	O
Labs:	O
===========	O
___	O
07:50PM	O
BLOOD	O
WBC-18.5*	O
RBC-3.81*	O
Hgb-7.8*	O
Hct-27.0*	O
MCV-71*	O
MCH-20.5*	O
MCHC-28.9*	O
RDW-20.2*	O
RDWSD-51.2*	O
Plt	O
___	O
___	O
07:50PM	O
BLOOD	O
Neuts-77.5*	O
Lymphs-14.3*	O
Monos-7.2	O
Eos-0.2*	O
Baso-0.3	O
Im	O
___	O
AbsNeut-14.32*	O
AbsLymp-2.63	O
AbsMono-1.32*	O
AbsEos-0.04	O
AbsBaso-0.05	O
___	O
07:50PM	O
BLOOD	O
Glucose-90	O
UreaN-16	O
Creat-0.9	O
Na-143	O
K-4.9	O
Cl-104	O
HCO3-25	O
AnGap-14	O
___	O
07:47AM	O
BLOOD	O
CRP-66.5*	O
___	O
08:17AM	O
BLOOD	O
___	O
pO2-147*	O
pCO2-42	O
pH-7.41	O
calTCO2-28	O
Base	O
XS-2	O
Comment-GREEN	O
TOP	O
Interval	O
Labs:	O
=========	O
___	O
05:57AM	O
BLOOD	O
calTIBC-333	O
Ferritn-17	O
TRF-256	O
___	O
07:47AM	O
BLOOD	O
CRP-66.5*	O
___	O
08:17AM	O
BLOOD	O
___	O
pO2-147*	O
pCO2-42	O
pH-7.41	O
calTCO2-28	O
Base	O
XS-2	O
Comment-GREEN	O
TOP	O
___	O
08:17AM	O
BLOOD	O
Lactate-1.4	O
Microbiology:	O
==========	O
___	O
URINE	O
CULTURE	O
(Final	O
___:	O
MIXED	O
BACTERIAL	O
FLORA	O
(	O
>=	O
3	O
COLONY	O
TYPES),	O
CONSISTENT	O
WITH	O
SKIN	O
AND/OR	O
GENITAL	O
CONTAMINATION.	O
___	O
BLOOD	O
CULTURE	O
x2:	O
no	O
growth	O
___	O
BLOOD	O
CULTURE	O
x2:	O
NGTD	O
___	O
URINE	O
CULTURE	O
(Final	O
___:	O
YEAST.	O
10,000-100,000	O
CFU/mL.	O
Discharge	O
Labs:	O
===========	O
___	O
07:10PM	O
BLOOD	O
WBC-19.0*	O
RBC-3.26*	O
Hgb-7.7*	O
Hct-25.7*	O
MCV-79*	O
MCH-23.6*	O
MCHC-30.0*	O
RDW-25.6*	O
RDWSD-56.4*	O
Plt	O
___	O
___	O
06:56AM	O
BLOOD	O
Glucose-96	O
UreaN-14	O
Creat-0.8	O
Na-141	O
K-4.7	O
Cl-105	O
HCO3-26	O
AnGap-10	O
___	O
05:55AM	O
BLOOD	O
Calcium-8.5	O
Phos-4.4	O
Mg-1.9	O
Imaging:	O
=======	O
___	O
CTA	O
AORTA/BIFEM/ILIAC	O
R	O
IMPRESSION:	O
1.	O
Redemonstration	O
of	O
occlusion	O
of	O
the	O
distal	O
infrarenal	O
abdominal	O
aorta	O
at	O
the	O
site	O
of	O
the	O
bilateral	O
common	O
iliac	O
stents	O
with	O
reconstitution	O
of	O
flow	O
in	O
the	O
bilateral	O
common	O
iliac	O
arteries	O
from	O
multiple	O
collaterals.	O
2.	O
Three-vessel	O
runoff	O
is	O
identified	O
bilaterally	O
to	O
the	O
level	O
of	O
the	O
ankle,	O
with	O
slower	O
flow	O
noted	O
in	O
the	O
bilateral	O
anterior	O
tibial	O
and	O
peroneal	O
arteries.	O
The	O
dorsalis	O
pedis	O
arteries	O
are	O
not	O
well	O
visualized	O
on	O
either	O
side,	O
and	O
there	O
is	O
likely	O
retrograde	O
filling	O
of	O
the	O
right	O
dorsalis	O
pedis	O
from	O
multiple	O
plantar	O
arteries.	O
3.	O
Mild	O
to	O
moderate	O
stenosis	O
identified	O
in	O
the	O
abdominal	O
major	O
branches,	O
iliac	O
and	O
femoral	O
arteries,	O
due	O
to	O
atherosclerotic	O
calcified	O
and	O
noncalcified	O
plaque,	O
detailed	O
above.	O
4.	O
Possible	O
nonobstructing	O
2-3	O
mm	O
left	O
upper	O
renal	O
pole	O
stone	O
versus	O
vascular	O
calcification.	O
CXR	O
___	O
IMPRESSION:	O
No	O
previous	O
images.	O
Scatter	O
radiation	O
related	O
to	O
the	O
size	O
of	O
the	O
patient	O
greatly	O
obscures	O
detail.	O
Cardiac	O
silhouette	O
is	O
mildly	O
enlarged	O
without	O
definite	O
vascular	O
congestion,,	O
pleural	O
effusion,	O
or	O
acute	O
focal	O
pneumonia.	O
Other	O
labs:	O
___	O
07:00AM	O
BLOOD	O
VitB12-812	O
___	O
05:57AM	O
BLOOD	O
calTIBC-333	O
Ferritn-17	O
TRF-256	O
___	O
07:00AM	O
BLOOD	O
TSH-2.1	O
___	O
7:00	O
am	O
SEROLOGY/BLOOD	O
**FINAL	O
REPORT	O
___	O
RPR	O
w/check	O
for	O
Prozone	O
(Final	O
___:	O
NONREACTIVE.	O
Reference	O
Range:	O
Non-Reactive.	O
Discharge	O
labs:	O
___	O
07:10PM	O
BLOOD	O
WBC-19.0*	O
RBC-3.26*	O
Hgb-7.7*	O
Hct-25.7*	O
MCV-79*	O
MCH-23.6*	O
MCHC-30.0*	O
RDW-25.6*	O
RDWSD-56.4*	O
Plt	O
___	O
___	O
06:56AM	O
BLOOD	O
Glucose-96	O
UreaN-14	O
Creat-0.8	O
Na-141	O
K-4.7	O
Cl-105	O
HCO3-26	O
AnGap-10	O
___	O
05:55AM	O
BLOOD	O
Calcium-8.5	O
Phos-4.4	O
Mg-1.9	O
Brief	O
Hospital	O
Course:	O
Ms.	O
___	O
is	O
a	O
___	O
with	O
a	O
PMHx	O
of	O
severe	O
PVD,	O
obesity,	O
CAD	O
s/p	O
PCI	O
c/b	O
Lcirc	O
perforation,	O
T2DM,	O
HTN,	O
CML	O
s/p	O
SCT	O
c/b	O
GVHD,	O
and	O
chronic	O
pannus	O
ulcerations	O
who	O
presented	O
from	O
Wound	O
Clinic	O
initially	O
with	O
concern	O
for	O
worsening	O
arterial	O
disease.	O
She	O
was	O
found	O
to	O
have	O
stable	O
arterial	O
disease	O
but	O
persistent	O
ischemic	O
pannus	O
ulcers,	O
and	O
underwent	O
Panniculectomy	O
on	O
___	O
with	O
plastic	O
surgery.	O
Course	O
also	O
complicated	O
by	O
UTI	B-Urinary_tract_infection
s/p	O
7d	O
abx,	O
delirium	B-Delirium
on	O
presumed	O
dementia,	B-Dementia
and	O
anemia.	O
#CHRONIC	O
PANNUS	O
ULCERATIONS	O
#NUTRITION	O
Patient	O
with	O
chronic	O
MRSA-infected	O
ulcerations	O
of	O
the	O
intertriginous	O
zone	O
of	O
her	O
pannus	O
requiring	O
multiple	O
hospitalizations.	O
Plastics	O
has	O
been	O
following	O
as	O
outpatient	O
with	O
for	O
consideration	O
of	O
panniculectomy	O
after	O
medical	O
clearance.	O
Wound	O
care	O
nurse	O
consulted.	O
Wounds	O
were	O
redressed	O
Qd.	O
Plastic	O
surgery	O
team	O
requested	O
nutrition,	O
dermatology,	O
and	O
cardiology	O
evaluation	O
for	O
pre-operative	O
assessment.	O
Per	O
nutrition,	O
patient	O
continued	O
on	O
multivitamin	O
with	O
minerals,	O
and	O
continued	O
on	O
10	O
day	O
course	O
of	O
ascorbic	O
acid	O
___	O
daily	O
(___)	O
and	O
10	O
day	O
course	O
of	O
vitamin	O
A	O
___	O
units	O
(___).	O
Zinc	O
level	O
was	O
sent,	O
normal.	O
Dermatology	O
thought	O
the	O
most	O
likely	O
etiology	O
of	O
her	O
ulcers	O
was	O
her	O
arterial	O
disease,	O
less	O
likely	O
infectious	O
or	O
pyoderma	O
gangrenosum.	O
Cardiology	O
evaluated	O
patient	O
to	O
perform	O
pre-operative	O
risk	O
stratification,	O
was	O
considering	O
intervention	O
given	O
her	O
history	O
of	O
CAD	O
with	O
Lcirc	O
CTO,	O
but	O
decided	O
against	O
this	O
given	O
small	O
affected	O
territory	O
and	O
presence	O
of	O
collaterals.	O
She	O
was	O
deemed	O
to	O
have	O
at	O
least	O
3	O
risk	O
factors,	O
corresponding	O
to	O
a	O
predicted	O
risk	O
of	O
~9%	O
for	O
major	O
cardiac	O
complications,	O
recommended	O
continuing	O
aspirin	O
but	O
from	O
cardiac	O
standpoint	O
does	O
not	O
need	O
DAPT.	O
Uncomplicated	O
Panniculectomy	O
was	O
completed	O
on	O
___.	O
Wound	O
vac	O
and	O
2	O
JP	O
drains	O
were	O
left	O
in	O
place	O
on	O
discharge	O
with	O
plan	O
for	O
followup	O
in	O
Plastic	O
Surgery	O
clinic	O
on	O
___	O
for	O
removal.	O
#	O
PERIPHERAL	O
VASCULAR	O
DISEASE	O
#	O
ARTERIAL	O
ULCERS	O
#	O
GANGRENE	O
of	O
MULTIPLE	O
TOES	O
Patient	O
with	O
history	O
of	O
severe	O
PVD	O
s/p	O
bilateral	O
iliac	O
stenting	O
with	O
subsequent	O
occlusion.	O
She	O
has	O
had	O
a	O
long	O
standing	O
ulceration	O
on	O
the	O
right	O
first	O
toe	O
and	O
more	O
recently	O
pain	O
and	O
discoloration	O
on	O
the	O
left	O
second	O
and	O
third	O
toes.	O
She	O
was	O
recently	O
evaluated	O
as	O
outpatient	O
by	O
vascular	O
surgeon	O
Dr.	O
___	O
consideration	O
of	O
revascularization	O
vs.	O
amputation,	O
but	O
surgical	O
intervention	O
has	O
been	O
limited	O
by	O
her	O
recurrent	O
pannus	O
infections.	O
Patient	O
initially	O
presented	O
to	O
ED	O
given	O
c/f	O
no	O
palpable	O
pulses,	O
but	O
per	O
vascular	O
surgery	O
evaluation,	O
her	O
exam	O
is	O
stable	O
with	O
no	O
palpable	O
pulses	O
but	O
with	O
dopplerable	O
femoral	O
and	O
___	O
pulses.	O
CTA	O
with	O
e/o	O
3	O
vessel	O
runoff.	O
Vascular	O
surgery	O
with	O
no	O
plan	O
for	O
inpatient	O
surgical	O
intervention,	O
would	O
consider	O
bypass	O
after	O
panniculectomy.	O
Patient	O
continued	O
on	O
ASA,	O
clopidogrel,	O
and	O
atorvastatin.	O
#TOXIC	O
METABOLIC	O
ENCEPHALOPATHY	B-Delirium
#UTI	I-Urinary_tract_infection
#Cognitive	I-Unspecified_cognitive_impairment
impairment	B-Unspecified_cognitive_impairment
In	O
the	O
ED,	O
the	O
patient	O
became	O
acutely	O
agitated	B-Dementia
and	O
confused	B-Dementia
requiring	O
antipsychotics	O
and	O
a	O
1:1	O
sitter.	O
Potential	O
etiologies	O
included	O
infectious,	O
metabolic,	O
delirium,	B-Delirium
and	O
medications.	O
As	O
she	O
had	O
known	O
chronic	O
ulcers	O
on	O
her	O
pannus	O
with	O
leukocytosis	O
on	O
admission	O
(___	O
18),	O
initial	O
c/f	O
pannus	O
infection,	O
although	O
Plastics	O
team	O
eval	O
in	O
ED	O
with	O
low	O
concern	O
for	O
secondary	O
cellulitis.	O
Initial	O
ED	O
labs	O
without	O
clear	O
metabolic	O
derangement.	O
CXR	O
___	O
negative.	O
UA	O
showing	O
large	O
leuks,	O
neg	O
nitrites,	O
started	O
CTX/vanc	O
for	O
UTI,	B-Urinary_tract_infection
transitioned	O
to	O
Bactrim	O
to	O
complete	O
a	O
7d	O
course	O
(through	O
___.	O
Bcx,	O
Ucx	O
NGTD.	O
Patient	O
did	O
not	O
have	O
any	O
agitation	B-Dementia
after	O
transfer	O
to	O
the	O
floor,	O
although	O
had	O
ongoing	O
memory	B-Unspecified_cognitive_impairment
issues	B-Unspecified_cognitive_impairment
through	O
admission	O
(AxOx2,	O
aware	O
that	O
it	O
is	O
___	O
but	O
cannot	O
provide	O
correct	O
date),	O
some	O
inattention.	O
Per	O
discussion	O
with	O
daughters	O
this	O
may	O
be	O
baseline,	O
as	O
they	O
have	O
had	O
concerns	O
over	O
past	O
year	O
about	O
their	O
mother's	O
memory.	B-Unspecified_cognitive_impairment
They	O
questioned	O
her	O
ability	O
to	O
care	O
for	O
herself	O
at	O
her	O
assisted	O
living	O
facility.	O
___	O
evaluated	O
her	O
and	O
recommended	O
rehab.	O
#URINARY	O
RETENTION	O
Patient	O
was	O
found	O
to	O
have	O
urinary	O
retention	O
on	O
bladder	O
scans.	O
It	O
was	O
thought	O
this	O
could	O
be	O
related	O
to	O
her	O
UTI	B-Urinary_tract_infection
but	O
it	O
did	O
not	O
resolve.	O
She	O
was	O
not	O
symptomatic.	O
IT	O
was	O
felt	O
she	O
likely	O
has	O
baseline	O
urinary	B-Urinary_incontinence
retention,	O
with	O
overflow	O
incontinence.	B-Urinary_incontinence
Outpatient	O
urinary	O
retention	O
was	O
arranged.	O
#MICROCYTIC	O
ANEMIA	O
#IRON	O
DEFICIENCY	O
Baseline	O
Hgb	O
___.	O
Hgb	O
7.8	O
on	O
presentation	O
and	O
stable.	O
Reported	O
history	O
of	O
PUD	O
on	O
PPI.	O
Home	O
omeprazole	O
continued	O
as	O
inpatient.	O
Daily	O
hemoglobin/hematocrit	O
trended	O
and	O
stable	O
during	O
admission.	O
Active	O
T&S	O
maintained	O
for	O
patient.	O
Did	O
receive	O
1	O
pRBC	O
transfusion	O
as	O
inpatient.	O
Received	O
IV	O
Iron	O
infusions	O
for	O
severe	O
iron	O
deficiency.	O
#Generalized	O
Body	O
Pain	O
Patient	O
endorsing	O
severe	O
total	O
body	O
pain,	O
appears	O
to	O
be	O
located	O
in	O
the	O
abdomen	O
and	O
around	O
this	O
pressure	B-Pressure_injury
ulcers.	B-Pressure_injury
Have	O
been	O
up	O
titrating	O
her	O
pain	O
regimen	O
carefully	O
given	O
history	O
of	O
sedation	O
with	O
large	O
doses	O
of	O
oral	O
Dilaudid.	O
Gave	O
Tylenol	O
to	O
1g	O
Q6H	O
standing,	O
increased	O
Tramadol,	O
added	O
PO	O
dilaudid	O
for	O
better	O
pain	O
control.	O
#Arm	O
tremors	O
Her	O
family	O
noted	O
new	O
tremors	O
that	O
appear	O
to	O
be	O
in	O
both	O
arms	O
and	O
into	O
and	O
occasionally	O
whole	O
body	O
tremors	O
that	O
started	O
while	O
she	O
is	O
in	O
rehab.	O
These	O
worsened	O
while	O
she	O
was	O
here	O
and	O
have	O
been	O
improving	O
over	O
the	O
last	O
few	O
days	O
prior	O
to	O
discharge.	O
There	O
was	O
concern	O
that	O
they	O
were	O
related	O
to	O
increased	O
pain.	O
Pain	O
regimen	O
has	O
been	O
up	O
titrated	O
to	O
good	O
effect.	O
At	O
this	O
point	O
her	O
tremor	O
is	O
most	O
pronounced	O
when	O
she	O
is	O
making	O
an	O
effort,	O
such	O
as	O
holding	O
herself	O
up	O
on	O
the	O
side	O
of	O
the	O
bed.	O
Likely	O
related	O
to	O
deconditioning	O
and	O
improved	O
dramatically	O
from	O
admission.	O
CHRONIC	O
ISSUES:	O
===============	O
#CAD	O
With	O
MI	O
s/p	O
PCI	O
complicated	O
by	O
LCx	O
perforation,	O
s/p	O
a	O
failed	O
CTO	O
PCI	O
in	O
___	O
and	O
subsequent	O
cath	O
in	O
___	O
that	O
showed	O
ongoing	O
CTO	O
of	O
LCx	O
with	O
distal	O
collaterals.	O
Continued	O
home	O
Isosorbide	O
Mononitrate	O
(Extended	O
Release)	O
30	O
mg	O
PO	O
DAILY,	O
Aspirin	O
81	O
mg	O
PO/NG	O
DAILY,	O
metoprolol,	O
and	O
atorvastatin.	O
Evaluated	O
by	O
cardiology	O
(see	O
above)	O
for	O
pre-operative	O
assessment	O
and	O
cleared	O
for	O
surgery	O
without	O
needing	O
preoperative	O
catheterization.	O
She	O
did	O
not	O
have	O
a	O
history	O
of	O
stent	O
and	O
after	O
consultation	O
with	O
cardiology	O
the	O
Plavix	O
was	O
discontinued.	O
#SACRAL	I-Pressure_injury
DECUBITUS	B-Pressure_injury
ULCER	B-Pressure_injury
Eschar	O
covered	O
sacral	B-Pressure_injury
wound	B-Pressure_injury
noted	O
on	O
R	O
buttock.	B-Pressure_injury
Patient	O
provided	O
with	O
Qd	O
wound	O
dressings.	O
On	O
___	O
after	O
her	O
panniculectomy	O
her	O
ulcer	O
was	O
debrided	O
in	O
the	O
OR	O
with	O
eschar	O
removal	O
and	O
found	O
to	O
be	O
Stage	O
II.	O
Wound	O
care	O
followed	O
along	O
and	O
provided	O
recommendations	O
for	O
care	O
as	O
inpatient.	O
#HYPERTENSION	O
Continued	O
on	O
home	O
amLODIPine	O
5	O
mg	O
PO/NG	O
DAILY	O
and	O
Losartan	O
Potassium	O
50	O
mg	O
PO/NG	O
DAILY.	O
#DMII	O
Maintained	O
on	O
insulin	O
sliding	O
scale	O
as	O
inpatient.	O
Initially	O
provided	O
with	O
insulin	O
glargine	O
45	O
U	O
QHS	O
but	O
blood	O
sugars	O
were	O
low,	O
downtitrated	O
to	O
12	O
units.	O
Metformin	O
held	O
and	O
restarted	O
on	O
discharge.	O
#OSA	O
Noted	O
to	O
desat	O
at	O
night	O
during	O
recent	O
hospitalizations.	O
No	O
e/o	O
of	O
desaturations	O
during	O
inpatient	O
stay.	O
Patient	O
did	O
not	O
require	O
supplemental	O
oxygen/CPAP.	O
#ANXIETY	O
#DEPRESSION	O
Continued	O
home	O
Escitalopram	O
Oxalate	O
10	O
mg	O
PO/NG	O
DAILY.	O
Transitional	O
Issues:	O
==============	O
[]	O
Consider	O
urology	O
f/u	O
as	O
outpatient	O
given	O
ongoing	O
urinary	O
retention	O
[]	O
Ensure	O
ongoing	O
Vascular	O
surgery	O
follow	O
up	O
and	O
management	O
of	O
PVD	O
and	O
necrotic	O
toes	O
[]	O
Please	O
follow	O
wound	O
care	O
recommendations	O
for	O
Foot	O
ulcer	O
management	O
[]	O
Patient	O
with	O
Stage	O
II	O
sacral	B-Pressure_injury
pressure	B-Pressure_injury
ulcer,	B-Pressure_injury
please	O
continue	O
wound	O
care	O
and	O
outpatient	O
management	O
[]	O
Follow	O
up	O
with	O
Plastic	O
surgery	O
on	O
___	O
for	O
assessment	O
of	O
pannus	O
wound	O
and	O
potential	O
removal	O
of	O
vac	O
and	O
drains.	O
[]	O
Wound	O
vac	O
should	O
be	O
return	O
to	O
___	O
at	O
___	O
appointment.	O
If	O
at	O
that	O
appointment	O
it	O
is	O
felt	O
that	O
her	O
wound	O
vac	O
should	O
be	O
continued,	O
then	O
please	O
substitute	O
for	O
rehab-provided	O
wound	O
vac.	O
[]	O
Neuro-cognitive	O
appointment	O
made	O
on	O
discharge	O
for	O
testing	O
given	O
c/f	O
dementia	B-Dementia
[]	O
Insulin	O
was	O
significantly	O
downtitrated	O
on	O
admission	O
from	O
45	O
U	O
lantus	O
to	O
12U	O
lantus	O
at	O
discharge	O
due	O
to	O
presumed	O
poor	O
oral	O
intake.	O
PLease	O
monitor	O
blood	O
sugars	O
and	O
increase	O
insulin	O
as	O
appropriate.	O
[]	O
Her	O
Clopidogrel	O
was	O
stopped	O
as	O
she	O
did	O
not	O
have	O
any	O
coronary	O
stents	O
and	O
vascular	O
surgery	O
felt	O
this	O
was	O
not	O
needed	O
for	O
her	O
iliac	O
stents	O
or	O
her	O
vascular	O
disease.	O
[]	O
She	O
had	O
persistent	O
anemia	O
during	O
this	O
admission,	O
was	O
transfused	O
one	O
unit	O
of	O
pRBCs	O
on	O
___	O
with	O
good	O
blood	O
count	O
response.	O
She	O
also	O
had	O
persistent	O
leukocytosis	O
(with	O
normal	O
differential),	O
but	O
given	O
her	O
history	O
of	O
CML	O
s/p	O
SCT	O
we	O
felt	O
it	O
was	O
important	O
for	O
her	O
to	O
follow	O
up	O
with	O
her	O
oncologist	O
at	O
___	O
___.	O
Please	O
arrange	O
this	O
for	O
___	O
weeks	O
after	O
discharge.	O
[]	O
f/u	O
CBC	O
in	O
1	O
week	O
to	O
ensure	O
not	O
Hgb	O
downtrending	O
(discharge	O
hgb	O
7.7).	O
Please	O
also	O
follow	O
up	O
her	O
WBC	O
count,	O
which	O
was	O
elevated	O
to	O
19	O
at	O
discharge.	O
If	O
WBC	O
continues	O
to	O
rise,	O
please	O
complete	O
infectious	O
evaluation	O
and	O
also	O
ensure	O
referral	O
to	O
her	O
Oncologist	O
at	O
___	O
who	O
has	O
been	O
following	O
her	O
for	O
CML.	O
[]	O
Continue	O
Bactrim	O
DS	O
BID	O
x7d	O
for	O
possible	O
infection	O
from	O
pannus	O
surgery.	O
(___)	O
*Patient	O
was	O
discharged	O
to	O
rehab	O
with	O
anticipated	O
length	O
of	O
stay	O
of	O
less	O
than	O
30	O
days.	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
Escitalopram	O
Oxalate	O
10	O
mg	O
PO	O
DAILY	O
2.	O
Losartan	O
Potassium	O
50	O
mg	O
PO	O
DAILY	O
3.	O
melatonin	O
3	O
mg	O
oral	O
QHS	O
4.	O
Omeprazole	O
20	O
mg	O
PO	O
DAILY	O
5.	O
amLODIPine	O
5	O
mg	O
PO	O
DAILY	O
6.	O
Cyanocobalamin	O
1000	O
mcg	O
PO	O
DAILY	O
7.	O
Isosorbide	O
Mononitrate	O
(Extended	O
Release)	O
30	O
mg	O
PO	O
DAILY	O
8.	O
MetFORMIN	O
(Glucophage)	O
1500	O
mg	O
PO	O
DAILY	O
9.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
10.	O
Ferrous	O
Sulfate	O
325	O
mg	O
PO	O
DAILY	O
11.	O
Pregabalin	O
50	O
mg	O
PO	O
TID	O
12.	O
Zolpidem	O
Tartrate	O
10	O
mg	O
PO	O
QHS	O
13.	O
rOPINIRole	O
1	O
mg	O
PO	O
BID	O
14.	O
TraMADol	O
50	O
mg	O
PO	O
Q4H:PRN	O
Pain	O
-	O
Moderate	O
15.	O
Nitroglycerin	O
SL	O
0.3	O
mg	O
SL	O
Q5MIN:PRN	O
chest	O
pain	O
16.	O
Acetaminophen	O
650	O
mg	O
PO	O
Q4H:PRN	O
Pain	O
-	O
Mild	O
17.	O
FoLIC	O
Acid	O
1	O
mg	O
PO	O
DAILY	O
18.	O
Vitamin	O
D	O
1000	O
UNIT	O
PO	O
DAILY	O
19.	O
Glargine	O
45	O
Units	O
Bedtime	O
Insulin	O
SC	O
Sliding	O
Scale	O
using	O
aspart	O
Insulin	O
20.	O
Clopidogrel	O
75	O
mg	O
PO	O
DAILY	O
21.	O
Metoprolol	O
Succinate	O
XL	O
50	O
mg	O
PO	O
DAILY	O
22.	O
HYDROmorphone	O
(Dilaudid)	O
2	O
mg	O
PO	O
BID:PRN	O
Pain	O
-	O
Severe	O
23.	O
Atorvastatin	O
80	O
mg	O
PO	O
QPM	O
CAD	O
Discharge	O
Medications:	O
1.	O
Bisacodyl	O
___AILY:PRN	O
constipation	B-Constipation
2.	O
Collagenase	O
Ointment	O
1	O
Appl	O
TP	O
DAILY	O
Sacral	B-Pressure_injury
Pressure	B-Pressure_injury
Ulcer	B-Pressure_injury
3.	O
Docusate	O
Sodium	O
100	O
mg	O
PO	O
BID	O
4.	O
Multivitamins	O
W/minerals	O
1	O
TAB	O
PO	O
DAILY	O
5.	O
Polyethylene	O
Glycol	O
17	O
g	O
PO	O
DAILY:PRN	O
constipation	B-Constipation
6.	O
Ramelteon	O
8	O
mg	O
PO	O
QHS:PRN	O
insomnia	O
Should	O
be	O
given	O
30	O
minutes	O
before	O
bedtime	O
7.	O
Senna	O
8.6	O
mg	O
PO	O
BID	O
8.	O
Sulfameth/Trimethoprim	O
DS	O
2	O
TAB	O
PO	O
BID	O
soft	O
tissue	O
infection,	O
persistent	O
leukocytosis	O
Duration:	O
7	O
Days	O
___	O
9.	O
Glargine	O
12	O
Units	O
Bedtime	O
Insulin	O
SC	O
Sliding	O
Scale	O
using	O
HUM	O
Insulin	O
10.	O
TraMADol	O
50-100	O
mg	O
PO	O
Q6H:PRN	O
Pain	O
-	O
Moderate	O
RX	O
*tramadol	O
50	O
mg	O
___	O
tablet(s)	O
by	O
mouth	O
q6h	O
PRN	O
Disp	O
#*15	O
Tablet	O
Refills:*0	O
11.	O
Acetaminophen	O
650	O
mg	O
PO	O
Q4H:PRN	O
Pain	O
-	O
Mild	O
12.	O
amLODIPine	O
5	O
mg	O
PO	O
DAILY	O
13.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
14.	O
Atorvastatin	O
80	O
mg	O
PO	O
QPM	O
CAD	O
15.	O
Cyanocobalamin	O
1000	O
mcg	O
PO	O
DAILY	O
16.	O
Escitalopram	O
Oxalate	O
10	O
mg	O
PO	O
DAILY	O
17.	O
Ferrous	O
Sulfate	O
325	O
mg	O
PO	O
DAILY	O
18.	O
FoLIC	O
Acid	O
1	O
mg	O
PO	O
DAILY	O
19.	O
Isosorbide	O
Mononitrate	O
(Extended	O
Release)	O
30	O
mg	O
PO	O
DAILY	O
20.	O
Losartan	O
Potassium	O
50	O
mg	O
PO	O
DAILY	O
21.	O
MetFORMIN	O
(Glucophage)	O
1500	O
mg	O
PO	O
DAILY	O
22.	O
Metoprolol	O
Succinate	O
XL	O
50	O
mg	O
PO	O
DAILY	O
23.	O
Nitroglycerin	O
SL	O
0.3	O
mg	O
SL	O
Q5MIN:PRN	O
chest	O
pain	O
24.	O
Omeprazole	O
20	O
mg	O
PO	O
DAILY	O
25.	O
Pregabalin	O
50	O
mg	O
PO	O
TID	O
RX	O
*pregabalin	O
[Lyrica]	O
50	O
mg	O
1	O
capsule(s)	O
by	O
mouth	O
three	O
times	O
a	O
day	O
Disp	O
#*15	O
Capsule	O
Refills:*0	O
26.	O
rOPINIRole	O
1	O
mg	O
PO	O
BID	O
27.	O
Vitamin	O
D	O
1000	O
UNIT	O
PO	O
DAILY	O
Discharge	O
Disposition:	O
Extended	O
Care	O
Facility:	O
___	O
___	O
Diagnosis:	O
TOXIC	O
METABOLIC	O
ENCEPHALOPATHY	B-Delirium
UTI	B-Urinary_tract_infection
ACUTE	O
URINARY	O
RETENTION	O
CHRONIC	O
PANNUS	O
ULCERATIONS	O
PERIPHERAL	O
VASCULAR	O
DISEASE	O
ARTERIAL	O
ULCERS	O
GANGRENE	O
of	O
MULTIPLE	O
TOES	O
MICROCYTIC	O
ANEMIA	O
___	O
IRON	O
DEFICIENCY	O
Generalized	O
Body	O
Pain	O
Discharge	O
Condition:	O
Mental	O
Status:	O
Confused	B-Delirium
-	O
sometimes.	O
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Out	B-Mobile_with_assistance
of	B-Mobile_with_assistance
Bed	B-Mobile_with_assistance
with	B-Mobile_with_assistance
assistance	B-Mobile_with_assistance
to	O
chair	O
or	O
wheelchair.	B-Mobile_with_aid
Discharge	O
Instructions:	O
Dear	O
Ms.	O
___,	O
It	O
was	O
a	O
pleasure	O
taking	O
care	O
of	O
you	O
here	O
at	O
___	O
___.	O
Why	O
you	O
were	O
here:	O
You	O
came	O
to	O
the	O
hospital	O
because	O
people	O
taking	O
care	O
of	O
you	O
at	O
Wound	O
Clinic	O
on	O
___	O
were	O
worried	O
about	O
you.	O
You	O
can	O
in	O
for	O
a	O
Vascular	O
surgery	O
evaluation,	O
a	O
UTI,	B-Urinary_tract_infection
and	O
for	O
surgery	O
to	O
remove	O
your	O
infected	O
ulcers.	O
What	O
we	O
did	O
while	O
you	O
were	O
here:	O
-	O
The	O
Vascular	O
surgeons	O
checked	O
on	O
your	O
leg	O
wounds	O
and	O
did	O
not	O
feel	O
a	O
surgery	O
was	O
necessary.	O
They	O
wanted	O
you	O
to	O
have	O
surgery	O
for	O
your	O
abdominal	O
ulcers	O
first.	O
-	O
The	O
Plastic	O
Surgeons	O
(Dr.	O
___	O
reviewed	O
you	O
abdominal	O
ulcers	O
and	O
performed	O
a	O
surgery	O
called	O
a	O
Panniculectomy	O
to	O
remove	O
the	O
ulcerated	O
skin.	O
This	O
procedure	O
went	O
well.	O
-	O
We	O
treated	O
you	O
for	O
a	O
urinary	B-Urinary_tract_infection
tract	B-Urinary_tract_infection
infection.	B-Urinary_tract_infection
-	O
We	O
gave	O
you	O
a	O
blood	O
transfusion	O
for	O
anemia.	O
-	O
You	O
had	O
some	O
confusion	B-Delirium
while	O
you	O
were	O
here.	O
Some	O
days	O
this	O
was	O
better	O
than	O
others,	O
but	O
overall	O
it	O
remained	O
stable.	O
We	O
recommend	O
that	O
you	O
see	O
a	O
neurologist	O
after	O
you	O
are	O
discharged	O
from	O
the	O
hospital.	O
What	O
to	O
do	O
when	O
you	O
go	O
home:	O
It	O
is	O
important	O
that	O
you	O
continue	O
to	O
take	O
the	O
medicines	O
prescribed	O
to	O
you	O
in	O
the	O
hospital.	O
Please	O
also	O
attend	O
all	O
of	O
your	O
outpatient	O
appointments	O
and	O
see	O
your	O
primary	O
care	O
doctor	O
within	O
5	O
days	O
after	O
discharge.	O
It	O
was	O
a	O
pleasure	O
taking	O
care	O
of	O
you.	O
We	O
wish	O
you	O
all	O
the	O
best	O
in	O
your	O
continued	O
recovery!	O
-Your	O
___	O
Care	O
Team	O
Followup	O
Instructions:	O
___	O

